Advertisement

Topics

Akebia Announces Fourth Quarter and Full-Year 2016 Financial Results

16:05 EST 6 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
-- Company to Host Conference Call at 4:30 p.m. Eastern Time -- Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through t...

Other Sources for this Article

Akebia
Theresa McNeely, 617-844-6113
SVP, Corporate Communications and Investor Relations
tmcneely@akebia.com

NEXT ARTICLE

More From BioPortfolio on "Akebia Announces Fourth Quarter and Full-Year 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement